Trust Company of Oklahoma’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $277K | Sell |
1,099
-238
| -18% | -$51.2K | 0.07% | 126 |
|
|
2026
Q1 | $291K | Buy |
1,337
+322
| +32% | +$71.4K | 0.08% | 116 |
|
|
2025
Q4 | $232K | Buy |
+1,015
| New | +$231K | 0.07% | 123 |
|
|
2025
Q1 | – | Sell |
-1,284
| Closed | -$228K | – | 132 |
|
|
2024
Q4 | $228K | Buy |
1,284
+132
| +11% | +$24.3K | 0.07% | 121 |
|
|
2024
Q3 | $227K | Buy |
+1,152
| New | +$215K | 0.07% | 119 |
|
|
2024
Q2 | – | Sell |
-1,185
| Closed | -$216K | – | 133 |
|
|
2024
Q1 | $216K | Sell |
1,185
-133
| -10% | -$22.9K | 0.08% | 128 |
|
|
2023
Q4 | $204K | Sell |
1,318
-37
| -3% | -$5.39K | 0.08% | 141 |
|
|
2023
Q3 | $202K | Sell |
1,355
-4,917
| -78% | -$722K | 0.08% | 140 |
|
|
2023
Q2 | $845K | Sell |
6,272
-364
| -5% | -$53.4K | 0.31% | 68 |
|
|
2023
Q1 | $1.06M | Hold |
6,636
| – | – | 0.41% | 55 |
|
|
2022
Q4 | $1.07M | Buy |
6,636
+83
| +1% | +$12.7K | 0.43% | 56 |
|
|
2022
Q3 | $879K | Sell |
6,553
-448
| -6% | -$64.3K | 0.44% | 53 |
|
|
2022
Q2 | $1.07M | Buy |
7,001
+448
| +7% | +$68.5K | 0.51% | 51 |
|
|
2022
Q1 | $1.06M | Sell |
6,553
-25
| -0.4% | -$3.63K | 0.41% | 59 |
|
|
2021
Q4 | $891K | Buy |
6,578
+234
| +4% | +$27.6K | 0.3% | 67 |
|
|
2021
Q3 | $684K | Sell |
6,344
-450
| -7% | -$51.4K | 0.24% | 76 |
|
|
2021
Q2 | $765K | Buy |
6,794
+450
| +7% | +$50.7K | 0.26% | 78 |
|
|
2021
Q1 | $687K | Buy |
6,344
+789
| +14% | +$84.4K | 0.25% | 81 |
|
|
2020
Q4 | $595K | Hold |
5,555
| – | – | 0.22% | 85 |
|
|
2020
Q3 | $487K | Buy |
+5,555
| New | +$523K | 0.2% | 87 |
|
|
2020
Q1 | $494K | Hold |
6,490
| – | – | 0.26% | 80 |
|
|
2019
Q4 | $575K | Sell |
6,490
-10
| -0.2% | -$830 | 0.23% | 87 |
|
|
2019
Q3 | $492K | Sell |
6,500
-10
| -0.2% | -$686 | 0.22% | 88 |
|
|
2019
Q2 | $473K | Sell |
6,510
-200
| -3% | -$15.7K | 0.21% | 85 |
|
|
2019
Q1 | $541K | Buy |
6,710
+190
| +3% | +$15.5K | 0.25% | 76 |
|
|
2018
Q4 | $601K | Sell |
6,520
-1,000
| -13% | -$87.9K | 0.32% | 65 |
|
|
2018
Q3 | $711K | Buy |
7,520
+875
| +13% | +$83K | 0.33% | 66 |
|
|
2018
Q2 | $616K | Sell |
6,645
-325
| -5% | -$31.7K | 0.31% | 68 |
|
|
2018
Q1 | $660K | Buy |
6,970
+250
| +4% | +$27.5K | 0.32% | 66 |
|
|
2017
Q4 | $650K | Hold |
6,720
| – | – | 0.31% | 66 |
|
|
2017
Q3 | $597K | Hold |
6,720
| – | – | 0.3% | 67 |
|
|
2017
Q2 | $487K | Hold |
6,720
| – | – | 0.25% | 74 |
|
|
2017
Q1 | $438K | Sell |
6,720
-445
| -6% | -$28K | 0.23% | 76 |
|
|
2016
Q4 | $449K | Sell |
7,165
-300
| -4% | -$18.3K | 0.24% | 75 |
|
|
2016
Q3 | $471K | Hold |
7,465
| – | – | 0.26% | 70 |
|
|
2016
Q2 | $462K | Sell |
7,465
-150
| -2% | -$9.14K | 0.26% | 66 |
|
|
2016
Q1 | $435K | Sell |
7,615
-475
| -6% | -$26.5K | 0.24% | 68 |
|
|
2015
Q4 | $479K | Sell |
8,090
-14
| -0.2% | -$806 | 0.27% | 66 |
|
|
2015
Q3 | $441K | Sell |
8,104
-375
| -4% | -$24.4K | 0.26% | 73 |
|
|
2015
Q2 | $570K | Sell |
8,479
-200
| -2% | -$13.1K | 0.3% | 67 |
|
|
2015
Q1 | $508K | Buy |
8,679
+330
| +4% | +$19.9K | 0.25% | 70 |
|
|
2014
Q4 | $546K | Sell |
8,349
-8,800
| -51% | -$555K | 0.27% | 73 |
|
|
2014
Q3 | $991K | Sell |
17,149
-229
| -1% | -$12.7K | 0.5% | 55 |
|
|
2014
Q2 | $981K | Buy |
17,378
+12,440
| +252% | +$653K | 0.47% | 57 |
|
|
2014
Q1 | $254K | Sell |
4,938
-30
| -0.6% | -$1.52K | 0.16% | 82 |
|
|
2013
Q4 | $262K | Sell |
4,968
-2,497
| -33% | -$123K | 0.18% | 80 |
|
|
2013
Q3 | $334K | Sell |
7,465
-3,679
| -33% | -$163K | 0.25% | 75 |
|
|
2013
Q2 | $461K | Buy |
+11,144
| New | +$487K | 0.36% | 60 |
|
Other funds holding ABBV
ECSS
ATO
Trust Company of Oklahoma's ABBV Position: Q2 2026 in Review
Trust Company of Oklahoma reduced its AbbVie (ABBV) stake by 18% in Q2 2026, selling an estimated $51.2K and leaving 1,099 shares worth $277K. The position accounts for 0.07% of the portfolio, ranked #126.
Trust Company of Oklahoma first reported a position in ABBV in Q2 2013 and has held it in 48 quarters since. The position peaked at $1.07M in Q4 2022. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Trust Company of Oklahoma held 1,099 shares of AbbVie worth $277K as of Q2 2026.
- Trust Company of Oklahoma sold 238 AbbVie shares in Q2 2026, an estimated $51.2K.
- AbbVie made up 0.07% of Trust Company of Oklahoma's portfolio in Q2 2026, its #126 holding.
- Trust Company of Oklahoma first reported a position in AbbVie in Q2 2013 and has held it in 48 quarters since.
- Trust Company of Oklahoma's AbbVie position peaked at $1.07M in Q4 2022.
- 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Trust Company of Oklahoma's 13F filing for Q2 2026, filed 14 Jul 2026.